Rowlandmiller & PARTNERS.ADV boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 884.6% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,363 shares of the healthcare conglomerate's stock after acquiring an additional 2,123 shares during the period. Rowlandmiller & PARTNERS.ADV's holdings in UnitedHealth Group were worth $737,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. Bayforest Capital Ltd boosted its holdings in shares of UnitedHealth Group by 685.7% in the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after purchasing an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its holdings in shares of UnitedHealth Group by 416.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. IAG Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group in the 1st quarter valued at $42,000. Copia Wealth Management acquired a new stake in shares of UnitedHealth Group in the 4th quarter valued at $42,000. Finally, O Brien Wealth Partners LLC boosted its holdings in shares of UnitedHealth Group by 74.0% during the 1st quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after acquiring an additional 37 shares in the last quarter. Institutional investors own 87.86% of the company's stock.
Analysts Set New Price Targets
Several equities research analysts recently weighed in on the company. UBS Group reissued a "buy" rating on shares of UnitedHealth Group in a report on Thursday, July 17th. Cantor Fitzgerald reissued an "overweight" rating and set a $440.00 price objective on shares of UnitedHealth Group in a report on Tuesday, August 26th. Hsbc Global Res downgraded UnitedHealth Group from a "hold" rating to a "moderate sell" rating in a report on Wednesday, May 21st. Wells Fargo & Company cut their target price on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a report on Monday, August 4th. Finally, Sanford C. Bernstein lifted their target price on UnitedHealth Group from $337.00 to $379.00 and gave the stock an "outperform" rating in a report on Friday, September 5th. Sixteen research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $358.95.
Get Our Latest Stock Analysis on UNH
UnitedHealth Group Stock Performance
UNH stock opened at $352.61 on Friday. The stock has a 50-day moving average price of $291.98 and a 200-day moving average price of $369.67. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market cap of $319.35 billion, a PE ratio of 15.28, a price-to-earnings-growth ratio of 2.31 and a beta of 0.45.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period last year, the business posted $6.80 earnings per share. The business's revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 annualized dividend and a dividend yield of 2.5%. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.